Galectin Therapeutics
GALT
#8188
Rank
S$0.22 B
Marketcap
$3.66
Share price
-3.37%
Change (1 day)
40.41%
Change (1 year)

Galectin Therapeutics (GALT) - Cash on Hand

Cash on Hand as of June 2024 : S$34.47 Million

According to Galectin Therapeutics's latest financial reports the company has S$34.47 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galectin Therapeutics - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31S$24.92 M-53.5%
2021-12-31S$53.6 M49.27%
2020-12-31S$35.9 M-43.91%
2019-12-31S$64.01 M467.74%
2018-12-31S$11.27 M176.11%
2017-12-31S$4.08 M-81.63%
2016-12-31S$22.23 M-39.19%
2015-12-31S$36.55 M-5.01%
2014-12-31S$38.48 M189.62%
2013-12-31S$13.28 M16.05%
2012-12-31S$11.45 M38.23%
2011-12-31S$8.28 M9.17%
2010-12-31S$7.58 M2053.45%
2009-12-31S$0.35 M-22.52%
2008-12-31S$0.45 M-76.04%
2007-12-31S$1.89 M-78.56%
2006-12-31S$8.85 M19.05%
2005-12-31S$7.43 M-57.42%
2004-12-31S$17.46 M35.1%
2003-12-31S$12.92 M287.75%
2002-12-31S$3.33 M20.76%
2001-12-31S$2.76 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$1.31 B 3,714.49%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.33 B 867.89%๐Ÿ‡บ๐Ÿ‡ธ USA